Labway provides integrated clinical testing, pathology, and precision‑medicine services for hospitals, research institutes, and pharmaceutical developers. It operates multi‑omics laboratories with high‑throughput sequencing, proteomics, and bioinformatics pipelines, delivering standardized, personalized diagnostic reports and supporting CRO, biobanking, and regional laboratory development.
Funding
Funding not disclosed
Founders
Product
Problem
Medical institutions and research labs often face fragmented diagnostic services, limited access to high‑throughput multi‑omics technologies, and inconsistent quality standards across regions, which hampers timely, precise disease diagnosis and slows translational research.
Solution
Labway (兰卫医学) offers an integrated suite of clinical testing, pathology, and precision‑medicine services that connects hospitals, academic institutes, and regional centers through standardized workflows and shared resources. The company builds and operates multi‑omics laboratories—including genomics, transcriptomics, proteomics, and cellular platforms—equipped with PCR, NGS, FISH, mass spectrometry, flow cytometry, and automated immunohistochemistry. Data from these platforms are processed with in‑house bioinformatics pipelines and interpreted by expert teams, delivering personalized diagnostic reports and supporting clinical decision‑making. Labway also provides regional laboratory construction, CRO support, and biobanking to enable cost‑effective, homogeneous testing across county‑level facilities, thereby elevating overall diagnostic capacity and accelerating research‑to‑clinic translation.
Target Audience
Primary customers are public hospitals, county‑level medical centers, and university‑affiliated research institutes that require standardized, high‑throughput diagnostic and multi‑omics services, as well as pharmaceutical companies seeking CRO and biobanking support for clinical development.
Features
- Comprehensive clinical testing portfolio (clinical chemistry, immunology, microbiology, molecular biology) staffed by hundreds of senior technologists.
- Full‑scale pathology services including real‑time consultation, remote diagnosis, frozen section, and multidisciplinary case review.
- Precision‑medicine platform with PCR, qPCR, ddPCR, FISH, mass spectrometry, NGS (1st‑, 2nd‑, 3rd‑generation), single‑cell sequencing (10x Genomics Chromium X, BD Rhapsody), spatial transcriptomics (Visium HD, Xenium), and single‑cell proteomics (Olink, TissueGnostics).
- Integrated bioinformatics and genetic interpretation pipelines supporting multi‑omics data integration, variant annotation, and clinical reporting.
- Regional center model that consolidates existing medical resources, standardizes testing procedures, and provides shared laboratory, pathology, public‑health, and training services to multiple hospitals.
- CRO capabilities covering pre‑market product testing, clinical trial support, and regulatory submission management.
- Secure biobanking and sample‑management infrastructure for long‑term storage and access to high‑quality specimens.